A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

Harry Buller; Anthonie Lensing; M Prins; G Agnelli; A Cohen; Alexander Gallus; F Misselwitz; G Raskob; Sebastian Schellong; Annelise Segers

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

Harry Buller, Anthonie Lensing, M Prins, G Agnelli, A Cohen, Alexander Gallus, F Misselwitz, G Raskob, Sebastian Schellong, Annelise Segers

Research output: Contribution to journal › Article › peer-review

330 Citations (Scopus)

Original language	English
Pages (from-to)	2242-2247
Number of pages	6
Journal	Blood
Volume	112
Issue number	6
Publication status	Published - 2008

Cite this

Buller, H., Lensing, A., Prins, M., Agnelli, G., Cohen, A., Gallus, A., Misselwitz, F., Raskob, G., Schellong, S., & Segers, A. (2008). A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study. Blood, 112(6), 2242-2247.

@article{cb9cd9c1aeba40b39b9b46c4a22a280e,

title = "A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study",

author = "Harry Buller and Anthonie Lensing and M Prins and G Agnelli and A Cohen and Alexander Gallus and F Misselwitz and G Raskob and Sebastian Schellong and Annelise Segers",

year = "2008",

language = "English",

volume = "112",

pages = "2242--2247",

journal = "Blood",

issn = "0006-4971",

number = "6",

}

Buller, H, Lensing, A, Prins, M, Agnelli, G, Cohen, A, Gallus, A, Misselwitz, F, Raskob, G, Schellong, S & Segers, A 2008, 'A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study', Blood, vol. 112, no. 6, pp. 2242-2247.

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study. / Buller, Harry; Lensing, Anthonie; Prins, M et al.

In: Blood, Vol. 112, No. 6, 2008, p. 2242-2247.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT dose-ranging study

AU - Buller, Harry

AU - Lensing, Anthonie

AU - Prins, M

AU - Agnelli, G

AU - Cohen, A

AU - Gallus, Alexander

AU - Misselwitz, F

AU - Raskob, G

AU - Schellong, Sebastian

AU - Segers, Annelise

PY - 2008

Y1 - 2008

M3 - Article

SN - 0006-4971

VL - 112

SP - 2242

EP - 2247

JO - Blood

JF - Blood

IS - 6

ER -